Phenotypic Screening for Pharmaceuticals Using Tissue Constructs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|5|2|181-189

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.5, Iss.2, 2004-04, pp. : 181-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing therapeutic pharmaceuticals for the treatment of soft-tissue sarcomas

By Patel Shreyaskumar R  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 12, 2002-12 ,pp. : 1789-1793

Informa Healthcare

Access to resources Recommend Favorite

Development of Tissue-Engineered Human Periodontal Ligament Constructs with Intrinsic Angiogenic Potential

By  

Cells Tissues Organs, Vol. 190, Iss. 6, 2009-04 ,pp. : 303-312

Karger

Access to resources Recommend Favorite

Finding New Hits in Neglected Disease Projects: Target or Phenotypic Based Screening?

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 10, 2011-05 ,pp. : 1284-1291

Bentham Science Publishers

Access to resources Recommend Favorite

Spectrophotometric methods for determining meloxicam in pharmaceuticals using batch and flow-injection procedures

By Garca M.S.   Sanchez-Pedreno C.   Albero M.I.   Mart J.  

European Journal of Pharmaceutical Sciences, Vol. 9, Iss. 3, 2000-01 ,pp. : 311-316

Elsevier

Access to resources Recommend Favorite

Perspective on Multi-Target Antiplatelet Therapies: High Content Phenotypic Screening as an Unbiased Source of Novel Polypharmacological Strategies

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 8, 2015-06 ,pp. : 622-629

Bentham Science Publishers

Access to resources Recommend Favorite